严重性
调节器
成文法
声誉
食品药品监督管理局
危害
业务
遗产管理(遗嘱认证法)
法律与经济学
公共行政
法学
政治学
经济
生物
基因
风险分析(工程)
遗传学
出处
期刊:Governance
[Wiley]
日期:2009-12-23
卷期号:23 (1): 133-159
被引量:115
标识
DOI:10.1111/j.1468-0491.2009.01470.x
摘要
When do regulatory agencies expand, following the emergence of novel technologies? This article presents a verbal model that suggests that a regulator is most likely to announce that it has statutory authority to regulate a novel technology when its reputation is at stake. This is most likely to occur when (1) new information becomes available to the regulator regarding the seriousness of the anticipated harm of a novel technology, or (2) a rival regulator attempts to formalize its regulatory authority or fails to do so although officially required to. A historical–institutional analysis of the temporal process leading to jurisdictional claims by the U.S. Food and Drug Administration over gene therapy, laboratory‐developed complex diagnostic tests, human tissue transplants, and human cloning supports the model's prediction.
科研通智能强力驱动
Strongly Powered by AbleSci AI